Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 15,000 shares at $319.13 ($4.7M) on 2013-09-30, disclosed to the SEC on 2013-10-02.
Scheduled sale ($4.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $302.46 | 300 | $91K | 1.9% |
| 2 | $308.91 | 100 | $31K | 0.7% |
| 3 | $309.73 | 100 | $31K | 0.7% |
| 4 | $311.59 | 300 | $93K | 2.0% |
| 5 | $312.53 | 3,887 | $1.2M | 25.8% |
| 6 | $313.47 | 3,705 |
| $1.2M |
| 24.7% |
| 7 | $314.31 | 2,608 | $820K | 17.4% |
| 8 | $315.51 | 800 | $252K | 5.4% |
| 9 | $316.54 | 1,200 | $380K | 8.1% |
| 10 | $317.48 | 900 | $286K | 6.1% |
| 11 | $318.27 | 700 | $223K | 4.7% |
| 12 | $319.13 | 400 | $128K | 2.7% |
| Total | $314.03 avg | 15,000 | $4.7M | 100% |
| Filing → |
| REGN | SELL | 2015-09-18 | $2.8M | — | Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |